{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:00:49Z","timestamp":1793048449071,"version":"4.5.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":1970,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s13311-018-0616-5","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T11:37:53Z","timestamp":1520249873000},"page":"361-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"title":["Glutamate and Its Receptors as Therapeutic Targets for Migraine"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-9081","authenticated-orcid":false,"given":"Jan","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-018-0616-5_bib1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1152\/physrev.00034.2015","article-title":"Pathophysiology of migraine: a disorder of sensory processing","volume":"97","author":"Goadsby","year":"2017","journal-title":"Physiological Reviews."},{"key":"10.1007\/s13311-018-0616-5_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00213-005-2200-z","article-title":"Ionotropic and metabotropic glutamate receptor structure and pharmacology","volume":"179","author":"Kew","year":"2005","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1007\/s13311-018-0616-5_bib3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacological reviews."},{"key":"10.1007\/s13311-018-0616-5_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/360163a0","article-title":"Positive feedback of glutamate exocytosis by metabotropic presynaptic receptor stimulation","volume":"360","author":"Herrero","year":"1992","journal-title":"Nature."},{"key":"10.1007\/s13311-018-0616-5_bib5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N","article-title":"An association between migraine and cutaneous allodynia","volume":"47","author":"Burstein","year":"2000","journal-title":"Ann Neurol."},{"key":"10.1007\/s13311-018-0616-5_bib6","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1212\/WNL.40.10.1582","article-title":"Neuroexcitatory plasma amino acids are elevated in migraine","volume":"40","author":"Ferrari","year":"1990","journal-title":"Neurology."},{"key":"10.1007\/s13311-018-0616-5_bib7","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1177\/0333102413487444","article-title":"Glutamate oxaloacetate transaminase: a new key in the dysregulation of glutamate in migraine patients","volume":"33","author":"Campos","year":"2013","journal-title":"Cephalalgia."},{"key":"10.1007\/s13311-018-0616-5_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1468-2982.1993.1302089.x","article-title":"Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks","volume":"13","author":"Martinez","year":"1993","journal-title":"Cephalalgia."},{"key":"10.1007\/s13311-018-0616-5_bib9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1468-2982.2008.01749.x","article-title":"Effective prophylactic treatments of migraine lower plasma glutamate levels","volume":"29","author":"Ferrari","year":"2009","journal-title":"Cephalalgia."},{"key":"10.1007\/s13311-018-0616-5_bib10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1526-4610.2007.00812.x","article-title":"Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine","volume":"47","author":"Vieira","year":"2007","journal-title":"Headache."},{"key":"10.1007\/s13311-018-0616-5_bib11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1468-2982.2004.00750.x","article-title":"Cerebrospinal fluid glutamate levels in chronic migraine","volume":"24","author":"Peres","year":"2004","journal-title":"Cephalalgia."},{"key":"10.1007\/s13311-018-0616-5_bib12","doi-asserted-by":"crossref","unstructured":"Nam JH, Lee HS, Kim J, Kim J, Chu MK. Salivary glutamate is elevated in individuals with chronic migraine. Cephalalgia. 2017;0333102417742366.","DOI":"10.1177\/0333102417742366"},{"key":"10.1007\/s13311-018-0616-5_bib13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1046\/j.1526-4610.1999.3909644.x","article-title":"Amino acids in the saliva of patients with migraine","volume":"39","author":"Rajda","year":"1999","journal-title":"Headache: The Journal of Head and Face Pain."},{"key":"10.1007\/s13311-018-0616-5_bib14","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/brain\/awx130","article-title":"Cortical glutamate in migraine","volume":"140","author":"Zielman","year":"2017","journal-title":"Brain."},{"key":"10.1007\/s13311-018-0616-5_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1468-2982.2009.01881.x","article-title":"Effect of systemic monosodium glutamate (MSG) on headache and pericranial muscle sensitivity","volume":"30","author":"Baad-Hansen","year":"2010","journal-title":"Cephalalgia."},{"key":"10.1007\/s13311-018-0616-5_bib16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0091-6749(97)80008-5","article-title":"The monosodium glutamate symptom complex: assessment in a double-blind, placebo-controlled, randomized study","volume":"99","author":"Yang","year":"1997","journal-title":"J Allergy Clin Immunol."},{"key":"10.1007\/s13311-018-0616-5_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"Vecsei","year":"2013","journal-title":"Nat Rev Drug Discov."},{"key":"10.1007\/s13311-018-0616-5_bib18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fneur.2017.00278","article-title":"The effect of systemic nitroglycerin administration on the kynurenine pathway in the rat","volume":"8","author":"Nagy-Grocz","year":"2017","journal-title":"Front Neurol."},{"key":"10.1007\/s13311-018-0616-5_bib19","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/0333102416678000","article-title":"Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: targets and anti-migraine mechanisms","volume":"37","author":"Greco","year":"2017","journal-title":"Cephalalgia."},{"key":"10.1007\/s13311-018-0616-5_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.expneurol.2012.05.002","article-title":"Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat","volume":"236","author":"Chauvel","year":"2012","journal-title":"Exp Neurol."},{"key":"10.1007\/s13311-018-0616-5_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s10194-016-0638-5","article-title":"Altered kynurenine pathway metabolites in serum of chronic migraine patients","volume":"17","author":"Curto","year":"2015","journal-title":"J Headache Pain."},{"key":"10.1007\/s13311-018-0616-5_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2350-11-103","article-title":"Common variants in the regulative regions of GRIA1 and GRIA3 receptor genes are associated with migraine susceptibility","volume":"11","author":"Formicola","year":"2010","journal-title":"BMC Med Genet."},{"key":"10.1007\/s13311-018-0616-5_bib23","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/head.12151","article-title":"Association of a GRIA3 gene polymorphism with migraine in an Australian case-control cohort","volume":"53","author":"Maher","year":"2013","journal-title":"Headache."},{"key":"10.1007\/s13311-018-0616-5_bib24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/head.12234","article-title":"Genetic analysis of GRIA2 and GRIA4 genes in migraine","volume":"54","author":"Gasparini","year":"2014","journal-title":"Headache."},{"key":"10.1007\/s13311-018-0616-5_bib25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10072-013-1535-1","article-title":"Lack of association between GRIA1 polymorphisms and haplotypes with migraine without aura or response to triptans","volume":"35","author":"Cargnin","year":"2014","journal-title":"Neurol Sci."},{"key":"10.1007\/s13311-018-0616-5_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s10194-016-0592-2","article-title":"Case-control study of GRIA1 and GRIA3 gene variants in migraine","volume":"17","author":"Fang","year":"2015","journal-title":"J Headache Pain."},{"key":"10.1007\/s13311-018-0616-5_bib27","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ng.3598","article-title":"Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine","volume":"48","author":"Gormley","year":"2016","journal-title":"Nat Genet."},{"key":"10.1007\/s13311-018-0616-5_bib28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/head.13053","article-title":"Genetics of migraine: insights into the molecular basis of migraine disorders","volume":"57","author":"Sutherland","year":"2017","journal-title":"Headache."},{"key":"10.1007\/s13311-018-0616-5_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3988\/jcn.2011.7.3.143","article-title":"Polymorphism of the glutamate transporter protein EAAT2 and migraine transformation into chronic daily headache","volume":"7","author":"Shin","year":"2011","journal-title":"J Clin Neurol."},{"key":"10.1007\/s13311-018-0616-5_bib30","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0306-4522(99)00446-7","article-title":"Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the alpha1A subunit of P\/Q type calcium channels","volume":"95","author":"Ayata","year":"2000","journal-title":"Neuroscience."},{"key":"10.1007\/s13311-018-0616-5_bib31","doi-asserted-by":"crossref","first-page":"967","DOI":"10.15252\/emmm.201505944","article-title":"Defective glutamate and K+ clearance by cortical astrocytes in familial hemiplegic migraine type 2","volume":"8","author":"Capuani","year":"2016","journal-title":"EMBO Mol Med."},{"key":"10.1007\/s13311-018-0616-5_bib32","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1212\/WNL.0b013e3182752cb8","article-title":"PRRT2 mutations cause hemiplegic migraine","volume":"79","author":"Riant","year":"2012","journal-title":"Neurology."},{"key":"10.1007\/s13311-018-0616-5_bib33","doi-asserted-by":"crossref","first-page":"183ra56","DOI":"10.1126\/scitranslmed.3005784","article-title":"Casein kinase idelta mutations in familial migraine and advanced sleep phase","volume":"5","author":"Brennan","year":"2013","journal-title":"Science translational medicine"},{"key":"10.1007\/s13311-018-0616-5_bib34","doi-asserted-by":"crossref","first-page":"P1.258","DOI":"10.1212\/WNL.82.10_supplement.P1.258","article-title":"The CK1\u03b4 T44A mutation affects nociceptive activation of the trigeminocervical complex in an in vivo model of migraine (P1.258)","volume":"82","author":"Hoffmann","year":"2014","journal-title":"Neurology."},{"key":"10.1007\/s13311-018-0616-5_bib35","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1523\/JNEUROSCI.1082-05.2005","article-title":"Physiological role for casein kinase 1 in glutamatergic synaptic transmission","volume":"25","author":"Chergui","year":"2005","journal-title":"J Neurosci."},{"key":"10.1007\/s13311-018-0616-5_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0304-3940(92)90339-9","article-title":"Excitatory amino acid binding sites in the trigeminal principal sensory and spinal trigeminal nuclei of the rat","volume":"141","author":"Tallaksen-Greene","year":"1992","journal-title":"Neuroscience Letters."},{"key":"10.1007\/s13311-018-0616-5_bib37","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nrn3057","article-title":"Diencephalic and brainstem mechanisms in migraine","volume":"12","author":"Akerman","year":"2011","journal-title":"Nat Rev Neurosci."},{"key":"10.1007\/s13311-018-0616-5_bib38","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1523\/JNEUROSCI.04-08-02133.1984","article-title":"Quantitative autoradiographic distribution of L-[3H]glutamate-binding sites in rat central nervous system","volume":"4","author":"Greenamyre","year":"1984","journal-title":"The Journal of Neuroscience."},{"key":"10.1007\/s13311-018-0616-5_bib39","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1523\/JNEUROSCI.04-09-02247.1984","article-title":"Localization of L-glutamate receptors in rat brain by quantitative autoradiography","volume":"4","author":"Halpain","year":"1984","journal-title":"The Journal of Neuroscience."},{"key":"10.1007\/s13311-018-0616-5_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0006-8993(01)03195-X","article-title":"Extracellular glutamate, aspartate and arginine increase in the ventral posterolateral thalamic nucleus during nociceptive stimulation","volume":"923","author":"Silva","year":"2001","journal-title":"Brain Research."},{"key":"10.1007\/s13311-018-0616-5_bib41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0304-3959(96)03156-9","article-title":"Excitatory amino release within spinal trigeminal nucleus after mustard oil injection into the temporomandibular joint region of the rat","volume":"67","author":"Bereiter","year":"1996","journal-title":"Pain."},{"key":"10.1007\/s13311-018-0616-5_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1113\/jphysiol.1982.sp014220","article-title":"An ionophoretic study of the responses of rat caudal trigeminal nucleus neurones to non-noxious mechanical sensory stimuli","volume":"327","author":"Hill","year":"1982","journal-title":"The Journal of Physiology."},{"key":"10.1007\/s13311-018-0616-5_bib43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0304-3959(95)00095-X","article-title":"The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity in central trigeminal neurons and blocks select endocrine and autonomic responses to corneal stimulation in the rat","volume":"64","author":"Bereiter","year":"1996","journal-title":"Pain."},{"key":"10.1007\/s13311-018-0616-5_bib44","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0306-4522(98)00536-3","article-title":"Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors","volume":"90","author":"Storer","year":"1999","journal-title":"Neuroscience."},{"issue":"Suppl 1","key":"10.1007\/s13311-018-0616-5_bib45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1129-2377-1-S1-P71","article-title":"Magnesium and memantine do not inhibit nociceptive neuronal activity in the trigeminocervical complex of the rat","volume":"1","author":"Hoffmann","year":"2013","journal-title":"J Headache Pain."},{"key":"10.1007\/s13311-018-0616-5_bib46","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/00001756-200106130-00015","article-title":"Co-localization of 5-HT1B\/1D\/1F receptors and glutamate in trigeminal ganglia in rats","volume":"12","author":"Ma","year":"2001","journal-title":"Neuroreport."},{"key":"10.1007\/s13311-018-0616-5_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2013.09.009","article-title":"Effect of metabotropic glutamate 5 receptor antagonists on morphine efficacy and tolerance in rats with neuropathic pain","volume":"718","author":"Zhou","year":"2013","journal-title":"European Journal of Pharmacology."},{"key":"10.1007\/s13311-018-0616-5_bib48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/jcbfm.1992.32","article-title":"The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression","volume":"12","author":"Lauritzen","year":"1992","journal-title":"J Cereb Blood Flow Metab."},{"key":"10.1007\/s13311-018-0616-5_bib49","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1152\/jn.00466.2004","article-title":"Protective effect of ifenprodil against spreading depression in the mouse entorhinal cortex","volume":"92","author":"Faria","year":"2004","journal-title":"J Neurophysiol."},{"key":"10.1007\/s13311-018-0616-5_bib50","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/jpet.106.117101","article-title":"Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine","volume":"321","author":"Peeters","year":"2007","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1007\/s13311-018-0616-5_bib51","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuropharm.2014.04.018","article-title":"The effect of ketamine on optical and electrical characteristics of spreading depolarizations in gyrencephalic swine cortex","volume":"84","author":"Sanchez-Porras","year":"2014","journal-title":"Neuropharmacology."},{"key":"10.1007\/s13311-018-0616-5_bib52","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.wnr.0000175250.33159.a9","article-title":"Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura","volume":"16","author":"Akerman","year":"2005","journal-title":"Neuroreport."},{"key":"10.1007\/s13311-018-0616-5_bib53","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1152\/jn.1987.57.3.869","article-title":"Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices","volume":"57","author":"Mody","year":"1987","journal-title":"Journal of Neurophysiology."},{"key":"10.1007\/s13311-018-0616-5_bib54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2010.11.021","article-title":"Effects of AMPA and clomethiazole on spreading depression cycles in the rat neocortex in vivo","volume":"653","author":"Addae","year":"2011","journal-title":"Eur J Pharmacol."},{"key":"10.1007\/s13311-018-0616-5_bib55","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist\u2014a review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacology."},{"key":"10.1007\/s13311-018-0616-5_bib56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2006.04.049","article-title":"Occipital afferent activation of second order neurons in the trigeminocervical complex in rat","volume":"403","author":"Le Doar\u00e9","year":"2006","journal-title":"Neuroscience Letters."},{"key":"10.1007\/s13311-018-0616-5_bib57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainres.2004.06.048","article-title":"Administration of MK-801 decreases c-Fos expression in the trigeminal sensory nuclear complex but increases it in the midbrain during experimental movement of rat molars","volume":"1021","author":"Hattori","year":"2004","journal-title":"Brain Research."},{"issue":"Pt 8","key":"10.1007\/s13311-018-0616-5_bib58","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/brain\/123.8.1703","article-title":"The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine","volume":"123","author":"Burstein","year":"2000","journal-title":"Brain."},{"key":"10.1007\/s13311-018-0616-5_bib59","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: a generator of pain hypersensitivity by central neural plasticity","volume":"10","author":"Latremoliere","year":"2009","journal-title":"The Journal of Pain."},{"key":"10.1007\/s13311-018-0616-5_bib60","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain."},{"key":"10.1007\/s13311-018-0616-5_bib61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0304-3959(91)90100-C","article-title":"The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states","volume":"44","author":"Woolf","year":"1991","journal-title":"Pain."},{"key":"10.1007\/s13311-018-0616-5_bib62","first-page":"58","article-title":"Evidence for spinal N-methyl-d-aspartate receptor involvement in prolonged chemical nociception in the rat","volume":"2016","author":"Haley","year":"1645","journal-title":"Brain Research."},{"key":"10.1007\/s13311-018-0616-5_bib63","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0014-2999(95)00449-U","article-title":"Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats","volume":"284","author":"Jackson","year":"1995","journal-title":"European Journal of Pharmacology."},{"key":"10.1007\/s13311-018-0616-5_bib64","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0014-2999(97)00072-1","article-title":"Excitatory amino acid receptor involvement in peripheral nociceptive transmission in rats","volume":"324","author":"Lawand","year":"1997","journal-title":"European Journal of Pharmacology."},{"key":"10.1007\/s13311-018-0616-5_bib65","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10194-008-0061-7","article-title":"Evidence of persistent central sensitization in chronic headaches: a multi-method study","volume":"9","author":"Filatova","year":"2008","journal-title":"The Journal of Headache and Pain."},{"key":"10.1007\/s13311-018-0616-5_bib66","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pain.2006.01.040","article-title":"Frequency of headache is related to sensitization: a population study","volume":"123","author":"Buchgreitz","year":"2006","journal-title":"Pain."},{"key":"10.1007\/s13311-018-0616-5_bib67","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1468-2982.2006.01248.x","article-title":"Increased prevalence of tension-type headache over a 12-year period is related to increased pain sensitivity. A population study","volume":"27","author":"Buchgreitz","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1007\/s13311-018-0616-5_bib68","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/head.12224","article-title":"Pathophysiology of medication overuse headache\u2014an update","volume":"54","author":"Srikiatkhachorn","year":"2014","journal-title":"Headache: The Journal of Head and Face Pain."},{"key":"10.1007\/s13311-018-0616-5_bib69","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.bjp.0702584","article-title":"Non-NMDA glutamate receptors modulate capsaicin induced c-fos expression within trigeminal nucleus caudalis","volume":"127","author":"Mitsikostas","year":"1999","journal-title":"Brit J Pharmacol."},{"key":"10.1007\/s13311-018-0616-5_bib70","first-page":"268","article-title":"GLUR5 antagonists as novel migraine therapies","volume":"21","author":"Johnson","year":"2001","journal-title":"Cephalagia."},{"key":"10.1007\/s13311-018-0616-5_bib71","first-page":"267","article-title":"IV LY293558, an AMPA\/KA receptor antagonist, is effective in migraine","volume":"21","author":"Ramadan","year":"2001","journal-title":"Cephalagia."},{"key":"10.1007\/s13311-018-0616-5_bib72","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuropharm.2008.08.023","article-title":"Kainate receptors: pharmacology, function and therapeutic potential","volume":"56","author":"Jane","year":"2009","journal-title":"Neuropharmacology."},{"key":"10.1007\/s13311-018-0616-5_bib73","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuropharm.2008.06.063","article-title":"A nomenclature for ligand-gated ion channels","volume":"56","author":"Collingridge","year":"2009","journal-title":"Neuropharmacology."},{"key":"10.1007\/s13311-018-0616-5_bib74","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0165-6147(98)01286-3","article-title":"Kainate receptors: subunits, synaptic localization and function","volume":"20","author":"Chittajallu","year":"1999","journal-title":"Trends in Pharmacological Sciences."},{"key":"10.1007\/s13311-018-0616-5_bib75","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1523\/JNEUROSCI.17-17-06611.1997","article-title":"Glutamate receptor subunits GluR5 and KA-2 are coexpressed in rat trigeminal ganglion neurons","volume":"17","author":"Sahara","year":"1997","journal-title":"The Journal of Neuroscience."},{"key":"10.1007\/s13311-018-0616-5_bib76","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/01.j.pain.0000460325.25762.c0","article-title":"Modulation of nociceptive dural input to the trigeminocervical complex through GluK1 kainate receptors","volume":"156","author":"Andreou","year":"2015","journal-title":"Pain."},{"key":"10.1007\/s13311-018-0616-5_bib77","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0896-6273(01)00479-2","article-title":"Direct presynaptic regulation of GABA\/glycine release by kainate receptors in the dorsal horn: an ionotropic mechanism","volume":"32","author":"Kerchner","year":"2001","journal-title":"Neuron."},{"key":"10.1007\/s13311-018-0616-5_bib78","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1523\/JNEUROSCI.22-18-08010.2002","article-title":"Kainate receptor subunits underlying presynaptic regulation of transmitter release in the dorsal horn","volume":"22","author":"Kerchner","year":"2002","journal-title":"The Journal of Neuroscience."},{"key":"10.1007\/s13311-018-0616-5_bib79","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/46290","article-title":"Kainate receptors are involved in synaptic plasticity","volume":"402","author":"Bortolotto","year":"1999","journal-title":"Nature."},{"key":"10.1007\/s13311-018-0616-5_bib80","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/40645","article-title":"Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons","volume":"388","author":"Castillo","year":"1997","journal-title":"Nature."},{"key":"10.1007\/s13311-018-0616-5_bib81","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/16469","article-title":"Kainate-receptor-mediated sensory synaptic transmission in mammalian spinal cord","volume":"397","author":"Li","year":"1999","journal-title":"Nature."},{"key":"10.1007\/s13311-018-0616-5_bib82","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0301-0082(03)00122-9","article-title":"Kainate receptors and synaptic transmission","volume":"70","author":"Huettner","year":"2003","journal-title":"Progress in Neurobiology."},{"key":"10.1007\/s13311-018-0616-5_bib83","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1476-5381.2009.00142.x","article-title":"Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation","volume":"157","author":"Andreou","year":"2009","journal-title":"Brit J Pharmacol."},{"key":"10.1007\/s13311-018-0616-5_bib84","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00001756-199603220-00012","article-title":"Peripheral administration of NMDA, AMPA or KA results in pain behaviors in rats","volume":"7","author":"Zhou","year":"1996","journal-title":"Neuroreport."},{"key":"10.1007\/s13311-018-0616-5_bib85","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1468-2982.1997.1707785.x","article-title":"Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study","volume":"17","author":"Goldstein","year":"1997","journal-title":"Cephalalgia."},{"key":"10.1007\/s13311-018-0616-5_bib86","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1046\/j.1468-2982.2001.00161.x","article-title":"Lanepitant, an NK-1 antagonist, in migraine prevention","volume":"21","author":"Goldstein","year":"2001","journal-title":"Cephalalgia."},{"key":"10.1007\/s13311-018-0616-5_bib87","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1468-2982.2004.00723.x","article-title":"LY293558, a novel AMPA\/GluR5 antagonist, is efficacious and well-tolerated in acute migraine","volume":"24","author":"Sang","year":"2004","journal-title":"Cephalalgia."},{"key":"10.1007\/s13311-018-0616-5_bib88","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/jpet.110.165993","article-title":"Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries","volume":"334","author":"Chan","year":"2010","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1007\/s13311-018-0616-5_bib89","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.291.8.965","article-title":"Topiramate for migraine prevention: a randomized controlled trial","volume":"291","author":"Brandes","year":"2004","journal-title":"JAMA."},{"key":"10.1007\/s13311-018-0616-5_bib90","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.61.4.490","article-title":"Topiramate in migraine prevention: results of a large controlled trial","volume":"61","author":"Silberstein","year":"2004","journal-title":"Arch Neurol."},{"key":"10.1007\/s13311-018-0616-5_bib91","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1368-5031.2005.00612.x","article-title":"Topiramate 100 mg\/day in migraine prevention: a pooled analysis of double-blinded randomised controlled trials","volume":"59","author":"Bussone","year":"2005","journal-title":"Int J Clin Pract."},{"key":"10.1007\/s13311-018-0616-5_bib92","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1177\/0333102411418259","article-title":"Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway","volume":"31","author":"Andreou","year":"2011","journal-title":"Cephalalgia."},{"key":"10.1007\/s13311-018-0616-5_bib93","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/86075","article-title":"Peripheral group I metabotropic glutamate receptors modulate nociception in mice","volume":"4","author":"Bhave","year":"2001","journal-title":"Nat Neurosci."},{"key":"10.1007\/s13311-018-0616-5_bib94","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cne.10671","article-title":"Expression of metabotropic glutamate receptors in rat meningeal and brain microvasculature and choroid plexus","volume":"461","author":"Gillard","year":"2003","journal-title":"The Journal of Comparative Neurology."},{"key":"10.1007\/s13311-018-0616-5_bib95","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s12031-013-0052-2","article-title":"Peripheral metabotropic glutamate receptor subtype 5 contributes to inflammation-induced hypersensitivity of the rat temporomandibular joint","volume":"51","author":"Li","year":"2013","journal-title":"Journal of Molecular Neuroscience."},{"key":"10.1007\/s13311-018-0616-5_bib96","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/acn3.302","article-title":"Metabotropic glutamate receptor 5: a target for migraine therapy","volume":"3","author":"Waung","year":"2016","journal-title":"Annals of Clinical and Translational Neurology."},{"key":"10.1007\/s13311-018-0616-5_bib97","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuroscience.2015.04.051","article-title":"Local group I mGluR antagonists reduce TMJ-evoked activity of trigeminal subnucleus caudalis neurons in female rats","volume":"299","author":"Tashiro","year":"2015","journal-title":"Neuroscience."},{"key":"10.1007\/s13311-018-0616-5_bib98","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/(SICI)1096-9861(19990712)409:4<549::AID-CNE3>3.0.CO;2-I","article-title":"Development of metabotropic glutamate receptors from trigeminal nuclei to barrel cortex in postnatal mouse","volume":"409","author":"Mu\u00f1oz","year":"1999","journal-title":"Journal of Comparative Neurology."},{"key":"10.1007\/s13311-018-0616-5_bib99","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(93)90227-C","article-title":"Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain","volume":"163","author":"Shigemoto","year":"1993","journal-title":"Neuroscience Letters."},{"key":"10.1007\/s13311-018-0616-5_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0028-3908(00)00113-1","article-title":"Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function: I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain","volume":"40","author":"Walker","year":"2001","journal-title":"Neuropharmacology."},{"key":"10.1007\/s13311-018-0616-5_bib101","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0028-3908(00)00114-3","article-title":"mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia","volume":"40","author":"Walker","year":"2001","journal-title":"Neuropharmacology."},{"key":"10.1007\/s13311-018-0616-5_bib102","doi-asserted-by":"crossref","first-page":"8310","DOI":"10.1523\/JNEUROSCI.2396-04.2004","article-title":"Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization","volume":"24","author":"Kawasaki","year":"2004","journal-title":"The Journal of Neuroscience."},{"key":"10.1007\/s13311-018-0616-5_bib103","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.neuropharm.2008.12.010","article-title":"Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the \u03bc-opioid receptor","volume":"56","author":"Schr\u00f6der","year":"2009","journal-title":"Neuropharmacology."},{"key":"10.1007\/s13311-018-0616-5_bib104","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/10799893.2014.885049","article-title":"Investigating the expression of metabotropic glutamate receptors in trigeminal ganglion neurons and satellite glial cells: implications for craniofacial pain","volume":"34","author":"Boye Larsen","year":"2014","journal-title":"Journal of Receptors and Signal Transduction."},{"key":"10.1007\/s13311-018-0616-5_bib105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cne.903220110","article-title":"Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat","volume":"322","author":"Shigemoto","year":"1992","journal-title":"Journal of Comparative Neurology."},{"key":"10.1007\/s13311-018-0616-5_bib106","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0306-4522(00)00265-7","article-title":"Contributions of mGlu1 and mGlu5 receptors to interactions with N-methyl-d-aspartate receptor-mediated responses and nociceptive sensory responses of rat thalamic neurons","volume":"100","author":"Salt","year":"2000","journal-title":"Neuroscience."},{"key":"10.1007\/s13311-018-0616-5_bib107","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1460-9568.1991.tb00045.x","article-title":"Excitatory actions of the metabotropic excitatory amino acid receptor agonist, trans-(\u00b1)-1-amino-cyclopentane-1,3-dicarboxylate (t-ACPD), on rat thalamic neurons in vivo","volume":"3","author":"Salt","year":"1991","journal-title":"European Journal of Neuroscience."},{"key":"10.1007\/s13311-018-0616-5_bib108","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/0028-3908(95)00052-8","article-title":"Modulation of sensory neurone excitatory and inhibitory responses in the ventrobasal thalamus by activation of metabotropic excitatory amino acid receptors","volume":"34","author":"Salt","year":"1995","journal-title":"Neuropharmacology."},{"key":"10.1007\/s13311-018-0616-5_bib109","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0197-0186(95)00146-8","article-title":"Characterization of the metabotropic glutamate receptors (mGluRs) which modulate GABA-mediated inhibition in the ventrobasal thalamus","volume":"29","author":"Salt","year":"1996","journal-title":"Neurochemistry International."},{"key":"10.1007\/s13311-018-0616-5_bib110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0301-0082(95)00047-X","article-title":"Functions of ionotropic and metabotropic glutamate receptors in sensory transmission in the mammalian thalamus","volume":"48","author":"Salt","year":"1996","journal-title":"Progress in Neurobiology."},{"key":"10.1007\/s13311-018-0616-5_bib111","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/cne.903600402","article-title":"Distributions of the mRNAs for L-2-amino-4-phosphonobutyrate-sensitive metabotropic glutamate receptors, mGluR4 and mGluR7, in the rat brain","volume":"360","author":"Ohishi","year":"1995","journal-title":"The Journal of Comparative Neurology."},{"key":"10.1007\/s13311-018-0616-5_bib112","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3940(95)12207-9","article-title":"Presynaptic localization of a metabotropic glutamate receptor, mGluR7, in the primary afferent neurons: an immunohistochemical study in the rat","volume":"202","author":"Ohishi","year":"1995","journal-title":"Neurosci Lett."},{"key":"10.1007\/s13311-018-0616-5_bib113","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3940(95)12299-0","article-title":"Immunohistochemical localization of a metabotropic glutamate receptor, mGluR7, in ganglion neurons of the rat; with special reference to the presence in glutamatergic ganglion neurons","volume":"204","author":"Li","year":"1996","journal-title":"Neuroscience Letters."},{"key":"10.1007\/s13311-018-0616-5_bib114","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/(SICI)1096-9861(19980413)393:3<332::AID-CNE6>3.0.CO;2-2","article-title":"Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: A light and electron microscopic study","volume":"393","author":"Kinoshita","year":"1998","journal-title":"The Journal of Comparative Neurology."},{"issue":"Supplement 1","key":"10.1007\/s13311-018-0616-5_bib115","first-page":"161","article-title":"A clinical electroencephalgraphic and trace element study with special reference to zinc, copper and magnesium in serum and cerebrospinal fluid (CSF) in cases of migraine","volume":"232","author":"Jain","year":"1985","journal-title":"Journal of Neurology"},{"key":"10.1007\/s13311-018-0616-5_bib116","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1468-2982.1992.1201021.x","article-title":"Serum and salivary magnesium levels in migraine and tension-type headache. Results in a group of adult patients","volume":"12","author":"Sarchielli","year":"1992","journal-title":"Cephalalgia."},{"key":"10.1007\/s13311-018-0616-5_bib117","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1526-4610.1989.hed2907416.x","article-title":"Low brain magnesium in migraine","volume":"29","author":"Ramadan","year":"1989","journal-title":"Headache."},{"key":"10.1007\/s13311-018-0616-5_bib118","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1177\/0333102415590239","article-title":"Diet and nutraceutical interventions for headache management: a review of the evidence","volume":"36","author":"Orr","year":"2016","journal-title":"Cephalalgia."},{"key":"10.1007\/s13311-018-0616-5_bib119","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1212\/CON.0000000000000211","article-title":"Nutraceutical and other modalities for the treatment of headache","volume":"21","author":"Tepper","year":"2015","journal-title":"Continuum (Minneap Minn)."},{"key":"10.1007\/s13311-018-0616-5_bib120","first-page":"943","article-title":"Topiramate in migraine prophylaxis\u2014results from a placebo-controlled trial with propranolol as an active control","volume":"251","author":"Diener","year":"2004","journal-title":"J Neurol."},{"key":"10.1007\/s13311-018-0616-5_bib121","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","article-title":"Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study","volume":"27","author":"Diener","year":"2007","journal-title":"Cephalalgia."},{"key":"10.1007\/s13311-018-0616-5_bib122","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/B:NERE.0000010456.92887.3b","article-title":"Modulation by topiramate of AMPA and kainate mediated calcium influx in cultured cerebral cortical, hippocampal and cerebellar neurons","volume":"29","author":"Poulsen","year":"2004","journal-title":"Neurochem Res."},{"key":"10.1007\/s13311-018-0616-5_bib123","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/B978-0-444-52899-5.00021-6","article-title":"Mechanisms of action of antiseizure drugs","volume":"108","author":"Porter","year":"2012","journal-title":"Handb Clin Neurol."},{"key":"10.1007\/s13311-018-0616-5_bib124","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1586\/17512433.2014.885835","article-title":"Efficacy and mechanism of anticonvulsant drugs in migraine","volume":"7","author":"Hoffmann","year":"2014","journal-title":"Expert Rev Clin Pharmacol."},{"key":"10.1007\/s13311-018-0616-5_bib125","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003154.pub5","article-title":"Memantine for dementia.","author":"McShane","year":"2006","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1007\/s13311-018-0616-5_bib126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(01)01872-9","article-title":"The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2\/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner","volume":"306","author":"Rammes","year":"2001","journal-title":"Neurosci Lett."},{"key":"10.1007\/s13311-018-0616-5_bib127","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.104.077172","article-title":"Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons","volume":"312","author":"Aracava","year":"2005","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1007\/s13311-018-0616-5_bib128","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1526-4610.2008.01083.x","article-title":"Memantine in the preventive treatment of refractory migraine","volume":"48","author":"Bigal","year":"2008","journal-title":"Headache."},{"key":"10.1007\/s13311-018-0616-5_bib129","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s10194-007-0406-7","article-title":"Memantine for prevention of migraine: a retrospective study of 60 cases","volume":"8","author":"Charles","year":"2007","journal-title":"J Headache Pain."},{"key":"10.1007\/s13311-018-0616-5_bib130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/head.12732","article-title":"Memantine for prophylactic treatment of migraine without aura: a randomized double-blind placebo-controlled study","volume":"56","author":"Noruzzadeh","year":"2016","journal-title":"Headache: The Journal of Head and Face Pain."},{"key":"10.1007\/s13311-018-0616-5_bib131","first-page":"E285","article-title":"Ketamine: an update on cellular and subcellular mechanisms with implications for clinical practice","volume":"20","author":"Iacobucci","year":"2017","journal-title":"Pain Physician."},{"key":"10.1007\/s13311-018-0616-5_bib132","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1570159X14666160309114549","article-title":"Molecular and cellular mechanisms of rapid-acting antidepressants ketamine and scopolamine","volume":"15","author":"Wohleb","year":"2017","journal-title":"Curr Neuropharmacol."},{"key":"10.1007\/s13311-018-0616-5_bib133","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s10194-016-0700-3","article-title":"Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series","volume":"17","author":"Lauritsen","year":"2016","journal-title":"J Headache Pain."},{"key":"10.1007\/s13311-018-0616-5_bib134","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/head.13013","article-title":"Ketamine infusions for treatment refractory headache","volume":"57","author":"Pomeroy","year":"2017","journal-title":"Headache."},{"key":"10.1007\/s13311-018-0616-5_bib135","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.0b013e3182824e66","article-title":"A randomized controlled trial of intranasal ketamine in migraine with prolonged aura","volume":"80","author":"Afridi","year":"2013","journal-title":"Neurology."},{"key":"10.1007\/s13311-018-0616-5_bib136","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.55.1.139","article-title":"Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine","volume":"55","author":"Kaube","year":"2000","journal-title":"Neurology."}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-018-0616-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-018-0616-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923015672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923015672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-018-0616-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:10:15Z","timestamp":1761808215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923015672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":136,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1878747923015672"],"URL":"https:\/\/doi.org\/10.1007\/s13311-018-0616-5","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glutamate and Its Receptors as Therapeutic Targets for Migraine","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-018-0616-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}